Porton Pharma Solutions' low P/E ratio is due to declining earnings and a bleak growth forecast. Investors see no significant potential for earnings improvement, keeping the share price from rising significantly soon.
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Porton Pharma Solutions Stock Forum
No comment yet